Paoletti is President of Oncology at GSK and brings to NuCana significant international experience in clinical development and commercial strategy having held a number of senior roles in oncology across the global pharmaceutical sector.
NuCana appoints Dr Paolo Paoletti to its Board of Directors
Paoletti is President of Oncology at GSK and brings to NuCana significant international experience in clinical development and commercial strategy having held a number of senior roles in oncology across the global pharmaceutical sector.
Tags
Related posts
- Researchers introduce new AI tool to help clinicians capture uncertainty in medical images
- New UK report highlights inequalities among people living with breast cancer
- ELRIG UK and SRG collaborate to advance life sciences professionals in drug discovery
- Study reveals how specific nasal cells protect against COVID-19 in paediatric patients
- UCL study reveals carbon beads could help reduce progression of liver disease
